294 related articles for article (PubMed ID: 3687806)
1. Vasodilators, antihypertensive therapy and the kidney.
Hollenberg NK
Am J Cardiol; 1987 Dec; 60(17):57I-60I. PubMed ID: 3687806
[TBL] [Abstract][Full Text] [Related]
2. The kidney and effective antihypertensive therapy.
Hollenberg NK
Am J Cardiol; 1985 Dec; 56(16):52H-55H. PubMed ID: 2866706
[TBL] [Abstract][Full Text] [Related]
3. Strategies in antihypertensive therapy: implications of the kidney.
Hollenberg NK
Am J Med; 1986 Dec; 81(6A):15-9. PubMed ID: 2879443
[TBL] [Abstract][Full Text] [Related]
4. The kidney and strategies for the treatment of hypertension.
Hollenberg NK
Am J Med; 1984 Oct; 77(4A):60-3. PubMed ID: 6207726
[TBL] [Abstract][Full Text] [Related]
5. The effects of antihypertensive therapy on renal function.
Rappelli A; Baldinelli A; Zingaretti O; Espinosa E; Salvi S; Fulgheri PD
J Hypertens Suppl; 1991 Dec; 9(3):S37-40. PubMed ID: 1686783
[TBL] [Abstract][Full Text] [Related]
6. Vasodilators, antihypertensive therapy, and the kidney.
Hollenberg NK
Circulation; 1987 Jun; 75(6 Pt 2):V39-42. PubMed ID: 2882875
[TBL] [Abstract][Full Text] [Related]
7. Endothelin-1-induced vasopressor responses in essential hypertension.
Kaasjager KA; Koomans HA; Rabelink TJ
Hypertension; 1997 Jul; 30(1 Pt 1):15-21. PubMed ID: 9231815
[TBL] [Abstract][Full Text] [Related]
8. Renal hemodynamics in essential and renovascular hypertension. Influence of captopril.
Hollenberg NK
Am J Med; 1984 May; 76(5B):22-8. PubMed ID: 6328983
[TBL] [Abstract][Full Text] [Related]
9. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
10. Renal protection in hypertensive patients: selection of antihypertensive therapy.
Wenzel RR
Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive therapy and renal function.
Mimran A
J Cardiovasc Pharmacol; 1996; 27 Suppl 3():S19-25. PubMed ID: 8872296
[TBL] [Abstract][Full Text] [Related]
12. Renal and endocrine effects of long-term converting enzyme inhibition as compared with calcium antagonism in essential hypertension.
Katzman PL; Henningsen NC; Fagher B; Thulin T; Hulthén UL
J Cardiovasc Pharmacol; 1990 Mar; 15(3):360-4. PubMed ID: 1691357
[TBL] [Abstract][Full Text] [Related]
13. Nephroprotection by antihypertensive agents.
Schmieder RE
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
[TBL] [Abstract][Full Text] [Related]
14. The kidney and antihypertensive therapy.
Hollenberg NK
Am J Cardiol; 1987 Jan; 59(2):76A-79A. PubMed ID: 2880492
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacological basis of antihypertensive drug therapy].
Kolck UW; Zaugg CE; Erne P
Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
[TBL] [Abstract][Full Text] [Related]
16. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of calcium antagonists and converting enzyme inhibitors on renal function under normal and hypertensive conditions.
Romero JC; Ruilope LM; Bentley MD; Fiksen-Olsen MJ; Lahera V; Vidal MJ
Am J Cardiol; 1988 Oct; 62(11):59G-68G. PubMed ID: 3051997
[TBL] [Abstract][Full Text] [Related]
18. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade.
Wysocki M; Andersson OK; Persson B; Bagge U
Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163
[TBL] [Abstract][Full Text] [Related]
19. The effect of converting enzyme inhibition on the enhanced proximal sodium reabsorption induced by chronic diuretic treatment in patients with essential hypertension.
van Schaik BA; Geyskes GG; Dorhout Mees EJ
Nephron; 1987; 47(3):167-72. PubMed ID: 2825050
[TBL] [Abstract][Full Text] [Related]
20. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.
Hallow KM; Lo A; Beh J; Rodrigo M; Ermakov S; Friedman S; de Leon H; Sarkar A; Xiong Y; Sarangapani R; Schmidt H; Webb R; Kondic AG
Am J Physiol Regul Integr Comp Physiol; 2014 May; 306(9):R647-62. PubMed ID: 24500431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
